TCR2, Avedro wrangle $145M in first life science IPOs of 2019
February 14, 2019 at 14:25 PM EST
After a year-end high, a crackdown on foreign investment and a government shutdown, Massachusetts saw its first biotech IPOs of 2019 this week.
